[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "Breast Cancer",
            "Metastatic Breast Cancer",
            "Malignant Neoplasm of the Breast",
            "mBC",
            "ER+/HER2-",
            "Locally Advanced Breast Cancer"
        ],
        "dcp_id": null,
        "interventional_model": "SEQUENTIAL_ASSIGNMENT",
        "lead_org": "Arvinas Estrogen Receptor, Inc.",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Inclusion Criteria:\r\n\r\n        Part A, Part B, and Part C:\r\n\r\n          -  Patients at least 18 years of age at the time of signing the informed consent.\r\n\r\n          -  Patients must have histologically or cytologically confirmed ER+ and HER2- advanced\r\n             breast cancer for which standard curative therapy is no longer effective or does not\r\n             exist.\r\n\r\n          -  Patients must have measurable or non-measurable disease by RECIST criteria\r\n             (version1.1), with radiologic tumor assessments performed within 28 days of the first\r\n             dose of therapy.\r\n\r\n          -  Patients must be willing to undergo a biopsy of accessible tumor within 4 weeks prior\r\n             to the initiation of study treatment and a follow-up biopsy on treatment for ER IHC\r\n             testing and PD studies. (Patients without accessible tumor tissue may be eligible\r\n             after discussion with the Medical Monitor.)\r\n\r\n          -  Women must be postmenopausal due to surgical or natural menopause.\r\n\r\n        Part A:\r\n\r\n        - Patients must have received at least 2 prior endocrine regimens in any setting\r\n        (neoadjuvant, adjuvant or advanced/metastatic) a CDK4/6 inhibitor and up to 3 prior\r\n        regimens of cytotoxic chemotherapy in the locally advanced or metastatic setting.\r\n\r\n        Part B:\r\n\r\n          -  Patients must have received at least 1 prior endocrine regimen for a minimum of 6\r\n             months in the locally advanced or metastatic setting; if more than 1 prior endocrine\r\n             regimen has been administered, only one of the regimens must have been administered\r\n             for a minimum of 6 months in the locally advanced or metastatic setting\r\n\r\n          -  Patients must have received a CDK4/6 inhibitor\r\n\r\n          -  Patients must have received up to 1 prior regimen of cytotoxic chemotherapy in the\r\n             locally advanced or metastatic setting\r\n\r\n          -  Women must be postmenopausal due to surgical or natural menopause.\r\n\r\n        Part C:\r\n\r\n          -  Patients must have received at least one prior endocrine regimen.\r\n\r\n          -  Patients must have received no more than two prior chemotherapy regimens for advanced\r\n             disease.\r\n\r\n          -  Women must be postmenopausal due to surgical or natural menopause.\r\n\r\n        Exclusion Criteria:\r\n\r\n        Part A, Part B, and Part C:\r\n\r\n          -  Patients with known symptomatic brain metastases requiring steroids (above physiologic\r\n             replacement doses). Patients with previously diagnosed brain metastases are eligible\r\n             if they have completed their treatment and have recovered from the acute effects of\r\n             radiation therapy or surgery prior to first dose of study drug, have discontinued\r\n             high-dose corticosteroid treatment for these metastases for at least 4 weeks and are\r\n             neurologically stable as judged by the Investigator.\r\n\r\n          -  Receipt of prior anti-cancer or other investigational therapy within 14 days prior to\r\n             the first administration of study drug.\r\n\r\n          -  Radiation therapy within 4 weeks of first dose of study drug or prior irradiation to\r\n             >25% of the bone marrow. Palliative radiation for the alleviation of pain due to bone\r\n             metastasis will be allowed during the study."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": null,
        "official_title": "A Phase 1/2, Open Label, Dose Escalation, and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-471 Alone and in Combination With Palbociclib (IBRANCE\u00ae) in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer, Who Have Received Prior Hormonal Therapy and Chemotherapy in the Locally Advanced/Metastatic Setting",
        "_phase_sort_order": 3,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "28 Days",
                "name": "Part A: Assessment of anti-tumor activity of ARV-471",
                "description": "Anti-tumor activity of ARV-471 will be assessed by evaluating clinical benefit response (CBR) rate based on the summation of complete responses (CRs), partial responses (PRs) and stable disease of 24 weeks duration or longer.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part A: Assessment of anti-tumor activity of ARV-471",
                "description": "Anti-tumor activity of ARV-471 will be assessed by evaluating disease control rate (complete response, partial response, stable disease).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part A: Assessment of anti-tumor activity of ARV-471",
                "description": "Anti-tumor activity of ARV-471 will be assessed by evaluating overall response rate per RECIST 1.1.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part A: Assessment of anti-tumor activity of ARV-471",
                "description": "Anti-tumor activity of ARV-471 will be assessed by evaluating time to event endpoints: progression free survival, duration of response.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part A: Assessment of pharmacokinetic parameter area under the concentration-time curve (AUC).",
                "description": "Concentration-time curve (AUC) for single and multiple dose of ARV-471 PK parameters will be assessed when applicable after a single dose and after multiple doses.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part A: Assessment of pharmacokinetic parameter maximum concentration (Cmax).",
                "description": "Maximum concentration (Cmax) for single and multiple dose of ARV-471 PK parameters will be assessed when applicable after a single dose and after multiple doses.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part A: Assessment of pharmacokinetic parameter minimum concentration (Cmin).",
                "description": "Minimum concentration (Cmin) for single and multiple dose of ARV-471 PK parameters will be assessed when applicable after a single dose and after multiple doses.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part A: Assessment of pharmacokinetic parameter time to maximum concentration (Tmax).",
                "description": "Time to maximum concentration (Tmax) for single and multiple dose of ARV-471 PK parameters will be assessed when applicable after a single dose and after multiple doses.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part A: Incidence of Dose Limiting Toxicities of ARV-471",
                "description": "First Cycle Dose limiting toxicities characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), timing, seriousness, and relationship to study drug",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part A: Incidence of laboratory abnormalities as a measure of safety and tolerability of ARV-471",
                "description": "Laboratory abnormalities as characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), and timing.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part A: Number of Patients with Adverse Events as a measure of safety and tolerability of ARV-471",
                "description": "Adverse events as characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), timing, seriousness, and relationship to study drug.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part B: Assessment of anti-tumor activity of ARV-471",
                "description": "Clinical benefit response rate based on the summation of CRs, PRs and stable disease of 24 weeks duration or longer",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part B: Assessment of anti-tumor activity of ARV-471",
                "description": "Anti-tumor activity of ARV-471 will be assessed by evaluating duration of response, progression-free survival and overall survival.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part B: Assessment of anti-tumor activity of ARV-471",
                "description": "Anti-tumor activity of ARV-471 will be assessed by evaluating overall response rate per RECIST 1.1 in patients with measurable disease at baseline.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part B: Evaluation of Safety and Tolerability",
                "description": "Further evaluation of safety and tolerability of ARV-471 will be based on adverse events as characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), timing, seriousness, and relationship to study drug.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part B: Evaluation of Safety and Tolerability",
                "description": "Further evaluation of safety and tolerability of ARV-471 will be based on Laboratory abnormalities as characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), and timing.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part B: Evaluation of Safety and Tolerability",
                "description": "To characterize the PK of ARV-471 (exposure and clearance) by using a population PK approach.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part C: Assessment of anti-tumor activity of ARV-471 in combination with palbociclib",
                "description": "Anti-tumor activity of ARV-471 in combination with palbociclib will be assessed by evaluating clinical benefit response (CBR) rate based on the summation of complete responses (CRs), partial responses (PRs) and stable disease of 24 weeks duration or longer.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part C: Assessment of anti-tumor activity of ARV-471 in combination with palbociclib",
                "description": "Anti-tumor activity of ARV-471 in combination with palbociclib will be assessed by evaluating overall response rate per RECIST 1.1 in patients with measurable disease at baseline.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part C: Assessment of anti-tumor activity of ARV-471 in combination with palbociclib",
                "description": "Anti-tumor activity of ARV-471 in combination with palbociclib will be assessed by evaluating time to event endpoints: progression free survival, duration of response.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part C:Assessment of pharmacokinetic parameter area under the concentration-time curve (AUC)",
                "description": "Concentration-time curve (AUC) for single and multiple dose of ARV-471 PK parameters will be assessed when applicable after a single dose and after multiple doses.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part C: Assessment of pharmacokinetic parameter maximum concentration (Cmax).",
                "description": "Maximum concentration (Cmax) for single and multiple dose of ARV-471 PK parameters will be assessed when applicable after a single dose and after multiple doses.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part C: Assessment of pharmacokinetic parameter minimum concentration (Cmin).",
                "description": "Minimum concentration (Cmin) for single and multiple dose of ARV-471 PK parameters will be assessed when applicable after a single dose and after multiple doses.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part C: Assessment of pharmacokinetic parameter time to maximum concentration (Tmax)",
                "description": "Time to maximum concentration (Tmax) for single and multiple dose of ARV-471 PK parameters will be assessed when applicable after a single dose and after multiple doses.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part C: Incidence of Dose Limiting Toxicities of combination ARV-471 + palbociclib",
                "description": "First cycle dose-limiting toxicities and determination of a maximum tolerated dose (MTD) if applicable among the doses evaluated",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part C: Incidence of laboratory abnormalities as a measure of safety and tolerability of combination ARV-471 + palbociclib",
                "description": "Laboratory abnormalities as characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), and timing",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "28 Days",
                "name": "Part C: Number of Patients with Adverse Events as a measure of safety and tolerability of combination ARV-471 + palbociclib",
                "description": "Adverse events as characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), timing, seriousness, and relationship to study drug combination",
                "type_code": "PRIMARY"
            }
        ],
        "phase": "I_II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 2,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04072952",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER Alpha Status",
                    "ER Status",
                    "ER-Alpha Status",
                    "ERA Status",
                    "ESR Status",
                    "ESR1 Status",
                    "ESRA Status",
                    "ESTRR Status",
                    "Estrogen Receptor",
                    "Estrogen Receptor 1 Status",
                    "Estrogen Receptor Alpha Status",
                    "NR3A1 Status",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Status"
                ],
                "nci_thesaurus_concept_id": "C16150",
                "name": "Estrogen Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C16612",
                    "C21295",
                    "C20420",
                    "C38349",
                    "C54362",
                    "C36292",
                    "C20103",
                    "C94299",
                    "C77140",
                    "C20709"
                ],
                "parents": [
                    "C38349",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proto-Oncogene, Transcription Factor"
                ],
                "nci_thesaurus_concept_id": "C20420",
                "name": "Transcription Factor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C54362",
                    "C16612"
                ],
                "parents": [
                    "C54362"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER and/or PR +",
                    "ER and/or PR Positive",
                    "Estrogen Receptor and/or Progesterone Receptor Positive"
                ],
                "nci_thesaurus_concept_id": "C101267",
                "name": "Hormone Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C177692",
                    "C16612",
                    "C3367",
                    "C28656",
                    "C21295",
                    "C20420",
                    "C38349",
                    "C54362",
                    "C36292",
                    "C94299",
                    "C77140",
                    "C20103",
                    "C20709",
                    "C35682"
                ],
                "parents": [
                    "C177692",
                    "C28656",
                    "C38349",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Expressed",
                    "Expression Detected"
                ],
                "nci_thesaurus_concept_id": "C177692",
                "name": "Expression Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C35682",
                    "C77140"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PGR",
                    "PR",
                    "Progesterone Receptor Gene"
                ],
                "nci_thesaurus_concept_id": "C28656",
                "name": "PGR Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103",
                    "C20709"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER",
                    "ESR1",
                    "Estrogen Receptor 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C38349",
                "name": "ESR1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103",
                    "C20709"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2 Status",
                    "Her2/Neu Value"
                ],
                "nci_thesaurus_concept_id": "C16152",
                "name": "HER2/Neu Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C16612",
                    "C17756",
                    "C21295",
                    "C20719",
                    "C25870",
                    "C36292",
                    "C25872",
                    "C94299",
                    "C77140",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C17756",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20709",
                "name": "Nuclear Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103"
                ],
                "parents": [
                    "C20103",
                    "C20420"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2",
                    "Erb-b2 Receptor Tyrosine Kinase 2 Gene",
                    "HER2",
                    "HER2/Neu",
                    "NEU"
                ],
                "nci_thesaurus_concept_id": "C17756",
                "name": "ERBB2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20719",
                    "C25870",
                    "C25872",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C94299",
                "name": "Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C35681",
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C25870",
                    "C25872",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C54362",
                "name": "Transcription Regulation Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER Alpha Positive",
                    "ER Positive",
                    "ER+",
                    "ER-Alpha Positive",
                    "ERA Positive",
                    "ESR Positive",
                    "ESR1 Positive",
                    "ESRA Positive",
                    "ESTRR Positive",
                    "Estrogen Receptor 1 Positive",
                    "Estrogen Receptor Alpha Positive",
                    "NR3A1 Positive",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Positive",
                    "Positive",
                    "Positive Estrogen Receptor"
                ],
                "nci_thesaurus_concept_id": "C15492",
                "name": "Estrogen Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C177692",
                    "C16612",
                    "C3367",
                    "C28656",
                    "C21295",
                    "C16150",
                    "C20420",
                    "C38349",
                    "C54362",
                    "C35682",
                    "C36292",
                    "C20103",
                    "C94299",
                    "C77140",
                    "C20709",
                    "C101267"
                ],
                "parents": [
                    "C101267",
                    "C16150",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ERBB2 Negative",
                    "HER-2 Negative",
                    "HER2 Negative"
                ],
                "nci_thesaurus_concept_id": "C68749",
                "name": "HER2/Neu Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C165233",
                    "C16612",
                    "C17756",
                    "C3367",
                    "C21295",
                    "C35681",
                    "C20719",
                    "C25870",
                    "C16152",
                    "C36292",
                    "C25872",
                    "C94299",
                    "C77140",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C16152",
                    "C165233",
                    "C17756"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2019-08-05",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage III Breast Cancer AJCC v8",
                    "Anatomic Stage III Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139541",
                "name": "Stage III Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139533"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IIIA Breast Carcinoma AJCC v8",
                    "Anatomic Stage IIIA Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139542",
                "name": "Stage IIIA Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139541"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IIIB Breast Cancer AJCC v8",
                    "Anatomic Stage IIIB Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139543",
                "name": "Stage IIIB Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139541"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IIIC Breast Carcinoma AJCC v8",
                    "Anatomic Stage IIIC Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139544",
                "name": "Stage IIIC Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139541"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IV Breast Carcinoma AJCC v8",
                    "Anatomic Stage IV Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139545",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139533"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage III Breast Carcinoma AJCC v8",
                    "Prognostic Stage III Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139582",
                "name": "Stage III Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139554"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage IIIA Breast Cancer AJCC v8",
                    "Prognostic Stage IIIA Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139583",
                "name": "Stage IIIA Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139582"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage IIIB Breast Cancer AJCC v8",
                    "Prognostic Stage IIIB Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139584",
                "name": "Stage IIIB Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139582"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage IIIC Breast Carcinoma AJCC v8",
                    "Prognostic Stage IIIC Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139585",
                "name": "Stage IIIC Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139582"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage IV Breast Cancer AJCC v8",
                    "Prognostic Stage IV Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139587",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139554"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153238",
                "name": "Metastatic Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C170728",
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C160920",
                "name": "Locally Advanced Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C148130",
                    "C153238"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162648",
                "name": "Advanced Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C153238",
                    "C153171"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Breast",
                    "Malignant Neoplasm of the Breast",
                    "Malignant Neoplasm of Breast",
                    "Malignant Breast Tumor",
                    "Malignant Tumor of Breast"
                ],
                "nci_thesaurus_concept_id": "C9335",
                "name": "Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2910",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Breast Disease",
                    "Breast Diseases"
                ],
                "nci_thesaurus_concept_id": "C26709",
                "name": "Breast Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170728",
                "name": "Metastatic Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9335",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Mammary Carcinoma",
                    "Carcinoma of Breast",
                    "Carcinoma of the Breast",
                    "Breast cancer, NOS",
                    "Cancer of Breast",
                    "Breast Carcinoma",
                    "Cancer of the Breast"
                ],
                "nci_thesaurus_concept_id": "C4872",
                "name": "Breast Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2916",
                    "C9335"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm of Breast",
                    "Neoplasm of the Breast",
                    "Tumor of Breast",
                    "Tumor of the Breast",
                    "Breast Tumor"
                ],
                "nci_thesaurus_concept_id": "C2910",
                "name": "Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C26709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36310",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153171",
                "name": "Advanced Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C9270"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Cancer by AJCC v8 Prognostic Stage Group",
                    "Breast Carcinoma by AJCC v8 Prognostic Stage"
                ],
                "nci_thesaurus_concept_id": "C139554",
                "name": "Breast Cancer by AJCC v8 Prognostic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C139532",
                "name": "Breast Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Anatomic Stage"
                ],
                "nci_thesaurus_concept_id": "C139533",
                "name": "Breast Cancer by AJCC v8 Anatomic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Cancer",
                    "Locally advanced",
                    "regional cancer",
                    "Locally Metastatic Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8524",
                "name": "Locally Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148130",
                "name": "Locally Advanced Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C3482"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "ARV-471-mBC-101",
        "active_sites_count": 9,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiestrogenic",
                            "Antiestrogens",
                            "Estrogen Antagonist",
                            "Antiestrogen Therapy Agent",
                            "Anti-Estrogens",
                            "Antiestrogen",
                            "Estrogen Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C481",
                        "name": "Antiestrogen Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129818",
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Tumor Agents",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Anti-Tumor Drugs",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormone Therapy Agent",
                            "Hormonal Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C147908",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1404",
                        "name": "Protein Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Protein Inhibitor",
                            "Antineoplastic Protein Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Pharmacologic Agent",
                            "Pharmaceuticals",
                            "Pharmaceutical Agent",
                            "Agent",
                            "Drug Substance",
                            "Pharmacological Substance"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Ibrance"
                        ],
                        "nci_thesaurus_concept_id": "C49176",
                        "name": "Palbociclib",
                        "description": "An orally available cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin-dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. This suppresses DNA replication and decreases tumor cell proliferation. CDK4 and 6 are serine/threonine kinases that are upregulated in many tumor cell types and play a key role in the regulation of cell cycle progression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2185",
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Drug",
                            "Enzyme Inhibitor Agent"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antihormone Agents",
                            "Hormone Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C547",
                        "name": "Antihormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Hormonal Therapeutic",
                            "Antineoplastic Hormonal Agent",
                            "Antineoplastic Endocrinal Agent"
                        ],
                        "nci_thesaurus_concept_id": "C129818",
                        "name": "Antineoplastic Hormonal/Endocrine Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908",
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C165420",
                        "name": "ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C481"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "CDK Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2185",
                        "name": "Cyclin-Dependent Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C1404"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "ARV-471",
                "description": "Parts A and B: ARV-471 administered QD or BID for 28 day cycles.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "ARV-471 and palbociclib (IBRANCE\u00ae)",
                "description": "Part C: Daily oral dosages of ARV-471 for 28 days in combination with palbociclib (IBRANCE\u00ae) for 21 days.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2019-06939",
        "why_study_stopped": null,
        "brief_summary": "This is a Phase 1/2 dose escalation and cohort expansion study and will assess the safety and\r\n      tolerability of ARV-471 alone and in combination with palbociclib (IBRANCE\u00ae) in patients with\r\n      estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-)\r\n      locally advanced or metastatic breast cancer, who have received prior hormonal therapy and\r\n      chemotherapy in the locally advanced/metastatic setting.",
        "brief_title": "A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE\u00ae) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer",
        "status_history": [
            {
                "status_date": "2019-08-05T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 170,
        "_current_trial_status_sort_order": 0,
        "start_date": "2019-08-05",
        "record_verification_date": "2022-01-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": "mBC",
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Breast"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2022-12-31",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]